PUBLISHER: IMARC | PRODUCT CODE: 1560961
PUBLISHER: IMARC | PRODUCT CODE: 1560961
The global bone and joint health ingredients market size reached US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.
Bone and joint health ingredients refer to the herbal and natural extracts and compounds that are rich in essential nutrients and added to food and beverages to promote bone growth. The ingredients are primarily obtained from plant and animal-based sources, including turmeric, Boswellia, tart cherries, eggshell membranes and chondroitin. They have a high content of amino acids, calcium, collagen, glucosamine, chondroitin, magnesium and vitamin K and D. They are added to soft gel, pill, powder and liquid-based pharmaceuticals, nutraceuticals and dietary supplements to improve the structural matrix of the bones and minimize the risks of fractures. They also aid in enhancing the strength and flexibility of the joints in the body to prevent arthritis and other temporary or chronic joint disorders.
The increasing prevalence of orthopedic disorders, such as rheumatoid arthritis, tennis elbow and ligament injuries, is one of the key factors driving the growth of the market. Moreover, rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. With the increasing health consciousness, there is a rising acceptance for dietary and nutritional supplements among the masses. Athletes and fitness enthusiasts are also widely adopting bone and joint health and sports supplements to prevent nutritional deficiencies, joint deterioration and subsequent injuries in the body. Additionally, various product innovations, such as the launch of natural and organically sourced bone and joint health ingredients that cater to the requirements of the vegan population, are contributing to the growth of the market. Other factors, including significant growth in the pharmaceutical industry, along with rising healthcare expenditure capacities of the masses, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bone and joint health ingredients market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on form, type, distribution channel, application and end user.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amway Corp. (Alticor Inc.), Bioiberica S.A.U, Glanbia PLC, Herbalife Nutrition Ltd., Innophos Holdings Inc., Kappa Bioscience, Koninklijke DSM NV, NOW Foods, NutriGold Inc., Rousselot Inc. (Darling Ingredients), Waitaki Bio and William Reed Group Ltd.